Wockhardt jump 13% as US FDA accepts NDA for Zaynich antibiotic in key milestone for Indian pharma
Shares of Indian pharmaceutical major Wockhardt rallied more than 13% on Monday ...
In
Economy
Will the Airbus share price rebound after the A320 recall?
Airbus share price moved sideways as investors assessed the impact of last ...
South Korea cyber crisis deepens as Coupang data leak exposes national vulnerabilities
The post South Korea cyber crisis deepens as Coupang data leak exposes ...
Ukraine peace hopes send gasoil crack plummeting; sanctions easing on Russia eyed
Hopes for a potential peace plan in Ukraine have sent shockwaves through ...
Why are the smartest investors abandoning Bitcoin for gold right now?
Gold is beating Bitcoin by a wide margin, and the explanation lies ...
An OpenAI IPO in 2026? Why it may not happen soon
As the AI boom continues, talk of a potential OpenAI IPO is ...
Winners vs. losers in a bruised November: can the S&P 500 recover in December?
The US stock market ended November on a softer footing than history ...
Best retail stocks to own heading into the 2025 holiday season
The post Best retail stocks to own heading into the 2025 holiday ...